The ‘Godzilla’ fat jab could rival Mounjaro by helping users shed up to a quarter of their body weight while improving blood pressure and cholesterol, research has found.
According to US researchers, Retatrutide is the best drug yet for obese or overweight patients with type 2 diabetes, who typically lose less weight on the blockbuster jabs than people without the condition.
The drug, commonly known as ‘Reta’, is still undergoing clinical trials but has been hailed as a potential ‘game changer’ for weight-loss, heart disease and osteoarthritis.
Now experts at Los Angeles Institute for Metabolic Research have found that nearly a third of
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
